Lataa...

Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B

AIM: To investigate serum interleukin (IL)-38 level and its clinical role in predicting virological response (VR) to telbivudine (LdT) in patients with chronic hepatitis B (CHB). METHODS: The study participants were divided into two groups; one group consisted of 43 healthy controls (HCs) and the ot...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:World J Gastroenterol
Päätekijät: Wang, Hong-Juan, Jiang, Yan-Fang, Wang, Xin-Rui, Zhang, Man-Li, Gao, Pu-Jun
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Baishideng Publishing Group Inc 2016
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4858634/
https://ncbi.nlm.nih.gov/pubmed/27182162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i18.4529
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!